Jiangxi Provincial Cancer Hospital
In research, Jiangxi Provincial Cancer Hospital stands highest in Medicine (#2,252 of 10,443 worldwide), Health Sciences (#3,163 of 11,982 worldwide) and Life Sciences (#4,881 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 11.7× its share of world research.
- World rank, 2022–2025
- #7,371 of 28,054 · #14,831 all time
- Rank in China
- #1,485 of 3,058
- Research works
- 640 ▲ 79% vs 2013–17
- Citations
- 7.2k 11.3 per fractional work
- Top-10% rate
- 19.7% record average 16.5%
- Open access
- 54% world 28%
What is Jiangxi Provincial Cancer Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,252 of 10,443 | 18.4% | 143 | #4425 | |
| Health SciencesDomain | #3,163 of 11,982 | 18.6% | 145 | #5934 | |
| Life SciencesDomain | #4,881 of 7,800 | 18.6% | 82 | #9219 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,409 of 3,579 | 18.4% | 64 | #7123 |
Each strip is that field’s whole ranked pool, with the notch where Jiangxi Provincial Cancer Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#4,425 #2,252
- Health Sciences#5,934 #3,163
- Life Sciences#9,219 #4,881
- Biochemistry, Genetics and Molecular Biology#7,123 #3,409
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Jiangxi Provincial Cancer Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 11.7× the share of its output that it takes of world research.
- OncologySubfield · 32.6 works12×
- Pulmonary and Respiratory MedicineSubfield · 28.2 works7.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.8×
- Immunology and Microbiology 3.6×
- Medicine 3.0×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Neuroscience 1.0×
- Physics and Astronomy 0.7×
- Chemistry 0.6×
- Veterinary 0.5×
- Agricultural and Biological Sciences 0.3×
- Computer Science 0.3×
- Nursing 0.2×
- Health Professions 0.2×
- Dentistry 0.2×
- Materials Science 0.2×
- Engineering 0.2×
- Mathematics 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Energy 0.1×
- Economics, Econometrics and Finance 0.1×
Who are the top researchers at Jiangxi Provincial Cancer Hospital?
Ranked on the composite score, Wuping Li lead among researchers whose main affiliation is Jiangxi Provincial Cancer Hospital.
- 1 Wuping Li China · #1,082,058 worldwide 18 citations · 16 works
Which keywords describe research at Jiangxi Provincial Cancer Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Tumor Microenvironment, Gene Expression, Radiotherapy, Immunotherapy, Oxidative Stress and Metastasis.
- Tumor Heterogeneity
- Radiomics
- Cetuximab
- Predictive Modeling
- Prognosis
- Neoadjuvant Therapy
- Biogenesis
- Metabolism
- Medical Imaging
- Immune Checkpoint Blockade
- Cancer Therapy
- Precision Medicine
- Ferroptosis
- Targeted Therapy
- Clinical Practice Guidelines
- Biomarkers
- Immunotherapy
- Radiotherapy
- Gene Expression
- Chemotherapy
- Cancer
- Tumor Microenvironment
- Oxidative Stress
- Inflammation
- Metastasis
- Cell Death
- Prognostic Factors
- Clinical Trials
- Lipid Peroxidation
- Regulation
- Survival
- Immunity
- PD-1 and PD-L1
- Epigenetic Regulation
- Texture Analysis
- Cancer Progression
- Feature Extraction
- Apoptosis
- Quantitative Analysis
- Survival Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer42▲ 13×40 topics
- Chemotherapy26▲ 15×20 topics
- Tumor Microenvironment26▲ 23×7 topics
- Gene Expression20▲ 13×12 topics
- Oxidative Stress19▲ 4.6×28 topics
- Radiotherapy18▲ 19×11 topics
- Inflammation17▲ 3.3×40 topics
- Immunotherapy15▲ 8.4×16 topics
- Metastasis14▲ 17×11 topics
- Biomarkers13▲ 7.5×12 topics
- Cell Death12▲ 21×6 topics
- Clinical Practice Guidelines12▲ 8.9×10 topics
- Prognostic Factors12▲ 11×12 topics
- Targeted Therapy11▲ 20×5 topics
- Clinical Trials10▲ 6.2×8 topics
- Ferroptosis10▲ 52×1 topic
- Lipid Peroxidation10▲ 38×1 topic
- Precision Medicine10▲ 8.3×6 topics
- Regulation9▲ 7.0×8 topics
- Cancer Therapy9▲ 6.5×15 topics
- Survival9▲ 27×4 topics
- Immune Checkpoint Blockade8▲ 31×1 topic
- Immunity8▲ 8.3×6 topics
- Medical Imaging8▲ 6.6×6 topics
- PD-1 and PD-L18▲ 31×1 topic
- Metabolism8▲ 6.5×17 topics
- Epigenetic Regulation8▲ 15×4 topics
- Biogenesis8▲ 18×3 topics
- Texture Analysis8▲ 13×2 topics
- Neoadjuvant Therapy8▲ 13×5 topics
- Cancer Progression7▲ 16×7 topics
- Prognosis7▲ 8.9×6 topics
- Feature Extraction7▲ 6.3×2 topics
- Predictive Modeling7▲ 10×2 topics
- Apoptosis7▲ 9.0×15 topics
- Cetuximab7▲ 33×2 topics
- Quantitative Analysis7▲ 14×2 topics
- Radiomics7▲ 23×1 topic
- Survival Analysis7▲ 9.9×6 topics
- Tumor Heterogeneity7▲ 23×1 topic
Which research topics does Jiangxi Provincial Cancer Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Radiomics and Machine Learning in Medical Imaging and Cancer-related molecular mechanisms research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 10 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 7 works
- 4 Cancer-related molecular mechanisms research Cancer Research 6 works
- 5 Head and Neck Cancer Studies Otorhinolaryngology 5 works
- 6 Lung Cancer Research Studies Oncology 5 works
- 7 RNA modifications and cancer Molecular Biology 5 works
- 8 MicroRNA in disease regulation Cancer Research 4 works
- 9 Immune cells in cancer Immunology 4 works
- 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Jiangxi Provincial Cancer Hospital's research output changed?
Output in 2018–2022 was 79% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nanchang
- Nanchang University
- Jiangxi Normal University
- East China Jiaotong University
- Nanchang Hangkong University
- Jiangxi Agricultural University
- Jiangxi University of Finance and Economics
- Jiangxi Science and Technology Normal University
- Jiangxi University of Water Resources and Electric Power
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.